Who are Placebo to montelukast chewable tablets's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Singulair, Accolate, Montelukast placebo granüle, Comparator: Montelukast, ICS/LABA and Montelukast, Montelukast,mometazon froat.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/placebo-to-montelukast-chewable-tablets.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Placebo to montelukast chewable tablets — Competitive Intelligence Brief

Placebo to montelukast chewable tablets (Placebo to montelukast chewable tablets) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Leukotriene receptor antagonist. Area: Respiratory / Immunology.

marketed Leukotriene receptor antagonist CysLT1 receptor (cysteinyl leukotriene type-1 receptor) Respiratory / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Placebo to montelukast chewable tablets (Placebo to montelukast chewable tablets) — Organon and Co. Montelukast is a leukotriene receptor antagonist that blocks cysteinyl leukotriene receptors to reduce airway inflammation and bronchoconstriction.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Placebo to montelukast chewable tablets TARGET	Placebo to montelukast chewable tablets	Organon and Co	marketed	Leukotriene receptor antagonist	CysLT1 receptor (cysteinyl leukotriene type-1 receptor)
Singulair	montelukast	Merck & Co.	marketed	Leukotriene receptor antagonist (LTRA)	Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2	1998-02-20
Accolate	ZAFIRLUKAST	Strides Pharma Intl	marketed	Leukotriene Receptor Antagonist [EPC]	Cysteinyl leukotriene receptor 1	1996-01-01
Montelukast placebo granüle	Montelukast placebo granüle	Kecioren Education and Training Hospital	marketed	Leukotriene receptor antagonist	CysLT1 receptor
Comparator: Montelukast	Comparator: Montelukast	Organon and Co	marketed	Cysteinyl leukotriene receptor antagonist (LTRA)	CysLT1 (cysteinyl leukotriene receptor 1)
ICS/LABA and Montelukast	ICS/LABA and Montelukast	The First Affiliated Hospital of Guangzhou Medical University	marketed	ICS/LABA combination with leukotriene receptor antagonist	Glucocorticoid receptor, beta-2 adrenergic receptor, cysteinyl leukotriene receptor (CysLT1)
Montelukast,mometazon froat	Montelukast,mometazon froat	Istanbul Training and Research Hospital	marketed	Leukotriene receptor antagonist + inhaled corticosteroid combination	Cysteinyl leukotriene receptor 1 (CysLT1) and glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Leukotriene receptor antagonist class)

Organon and Co · 2 drugs in this class
Hull University Teaching Hospitals NHS Trust · 2 drugs in this class
ALK-Abelló A/S · 1 drug in this class
King Abdullah International Medical Research Center · 1 drug in this class
SamA Pharmaceutical Co., Ltd · 1 drug in this class
Kecioren Education and Training Hospital · 1 drug in this class
GlaxoSmithKline · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Placebo to montelukast chewable tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-montelukast-chewable-tablets. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab